Nurofen Plus recalled over 'sabotage'

The makers of Nurofen Plus have recalled all remaining stock, saying sabotage is suspected in some packets.

Earlier, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an alert after three packs were found to contain an antipsychotic drug.

Reckitt Benckiser (UK) Ltd said it had heard reports of the wrong drug in two more batches of Nurofen Plus.

A spokesman said the firm was working with police on a formal investigation to find those responsible.

Consumers are advised to return any packs of Nurofen Plus to a pharmacy.

This report by Helen Fawkes features pharmacist Mary Walsh and Gerald Heddell, head of standards at MHRA.

  • Subsection
  • Published